Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 7
2004 13
2005 12
2006 12
2007 8
2008 11
2009 13
2010 8
2011 8
2012 13
2013 11
2014 10
2015 9
2016 4
2017 9
2018 11
2019 15
2020 12
2021 3
2022 2
2023 7
2024 10
2025 7
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Results by year

Filters applied: . Clear all
Page 1
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance.
Charles-Schoeman C, Buch MH, Dougados M, Bhatt DL, Giles JT, Ytterberg SR, Koch GG, Vranic I, Wu J, Wang C, Kwok K, Menon S, Rivas JL, Yndestad A, Connell CA, Szekanecz Z. Charles-Schoeman C, et al. Among authors: yndestad a. Ann Rheum Dis. 2023 Jan;82(1):119-129. doi: 10.1136/ard-2022-222259. Epub 2022 Sep 22. Ann Rheum Dis. 2023. PMID: 36137735 Free PMC article. Clinical Trial.
Chemokines and cardiovascular risk.
Aukrust P, Halvorsen B, Yndestad A, Ueland T, Øie E, Otterdal K, Gullestad L, Damås JK. Aukrust P, et al. Among authors: yndestad a. Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1909-19. doi: 10.1161/ATVBAHA.107.161240. Epub 2008 Jul 31. Arterioscler Thromb Vasc Biol. 2008. PMID: 18669888 Review.
Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study.
Buch MH, Bhatt DL, Charles-Schoeman C, Giles JT, Mikuls T, Koch GG, Ytterberg S, Nagy E, Jo H, Kwok K, Connell CA, Masri KR, Yndestad A. Buch MH, et al. Among authors: yndestad a. RMD Open. 2024 Apr 12;10(2):e003912. doi: 10.1136/rmdopen-2023-003912. RMD Open. 2024. PMID: 38609322 Free PMC article. Clinical Trial.
Activated platelets and atherosclerosis.
Aukrust P, Halvorsen B, Ueland T, Michelsen AE, Skjelland M, Gullestad L, Yndestad A, Otterdal K. Aukrust P, et al. Among authors: yndestad a. Expert Rev Cardiovasc Ther. 2010 Sep;8(9):1297-307. doi: 10.1586/erc.10.92. Expert Rev Cardiovasc Ther. 2010. PMID: 20828352 Review.
A vital role for complement in heart disease.
Lappegård KT, Garred P, Jonasson L, Espevik T, Aukrust P, Yndestad A, Mollnes TE, Hovland A. Lappegård KT, et al. Among authors: yndestad a. Mol Immunol. 2014 Oct;61(2):126-34. doi: 10.1016/j.molimm.2014.06.036. Epub 2014 Jul 16. Mol Immunol. 2014. PMID: 25037633 Free article. Review.
Inflammatory cytokines as biomarkers in heart failure.
Ueland T, Gullestad L, Nymo SH, Yndestad A, Aukrust P, Askevold ET. Ueland T, et al. Among authors: yndestad a. Clin Chim Acta. 2015 Mar 30;443:71-7. doi: 10.1016/j.cca.2014.09.001. Epub 2014 Sep 6. Clin Chim Acta. 2015. PMID: 25199849 Review.
197 results